BioCentury
ARTICLE | Clinical News

Spiros beclomethasone: Began Phase II/III trial

March 10, 1999 8:00 AM UTC

Dura Pharmaceuticals Inc. (DURA), San Diego, Calif. Product: Spiros beclomethasone, anti-inflammatory corticosteroid Indication: Asthma Status: DURA began a placebo-controlled, double-blind dose verif...